Top experts by indication / Oncology
Most active experts in Precursor Cell Lymphoblastic Leukemia-Lymphoma
2026 edition, data as of October 26, 2026
277 key opinion leaders in the directory are tagged to Precursor Cell Lymphoblastic Leukemia-Lymphoma. The tables below rank them by one public measure each: registered trials, citations, NIH awards and congress contributions. Each is a count from a named source, not a judgment about the person, and every row links a profile where the count can be checked.
Most registered trials
Registered clinical trials in this indication on which the person is a listed investigator, counted from ClinicalTrials.gov. 274 of the 277 people tagged to this indication have this count on record; the 25 highest are listed. Source: ClinicalTrials.gov.
| # | Expert | trials |
|---|---|---|
| 1 | Elias JabbourThe University of Texas MD Anderson Cancer Center, TX | 22 trials |
| 2 | Ibrahim AldossCity of Hope, CA | 15 trials |
| 3 | Brenda SandmaierFred Hutchinson Cancer Center, WA | 15 trials |
| 4 | Wendy StockUniversity of Chicago, IL | 9 trials |
| 5 | Sima JehaSt. Jude Children's Research Hospital, TN | 8 trials |
| 6 | Ryotaro NakamuraCity of Hope, CA | 8 trials |
| 7 | Ryan CassadayUniversity of Washington, WA | 8 trials |
| 8 | Nitin JainThe University of Texas MD Anderson Cancer Center | 7 trials |
| 9 | Mitchell CairoNew York Medical College, NY | 7 trials |
| 10 | Ajay GopalUniversity of Washington School of Medicine, WA | 7 trials |
| 11 | Noelle FreyUniversity of Pennsylvania, PA | 6 trials |
| 12 | David MaloneyFred Hutchinson Cancer Center, WA | 6 trials |
| 13 | Geoffrey UyWashington University School of Medicine, MO | 6 trials |
| 14 | Jorge CortesUniversity of Alabama at Birmingham (UAB), AL | 5 trials |
| 15 | Michael BurkeWI | 5 trials |
| 16 | Tanja GruberStanford University School of Medicine, CA | 5 trials |
| 17 | Partow KebriaeiThe University of Texas MD Anderson Cancer Center, TX | 5 trials |
| 18 | Ivana GojoJohns Hopkins University School of Medicine, MD | 5 trials |
| 19 | Seth KarolSt. Jude Children's Research Hospital, TN | 5 trials |
| 20 | Marie BleakleySeattle Children's Hospital, WA | 4 trials |
| 21 | Andrew PlaceMA | 4 trials |
| 22 | Lewis SilvermanNY | 4 trials |
| 23 | Elizabeth RaetzNYU Langone Health, NY | 4 trials |
| 24 | Brandon TriplettSt. Jude Children's Research Hospital, TN | 4 trials |
| 25 | Stephan GruppChildren's Hospital of Philadelphia, PA | 4 trials |
Most cited
Citations to the person's whole published record in OpenAlex, not only their work in this indication, among the people with at least two registered trials in it. 79 of the 277 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: OpenAlex.
| # | Expert | citations |
|---|---|---|
| 1 | Hagop KantarjianThe University of Texas MD Anderson Cancer Center, TX | 270,473 citations |
| 2 | Jorge CortesUniversity of Alabama at Birmingham (UAB), AL | 144,714 citations |
| 3 | Guillermo Garcia-ManeroThe University of Texas MD Anderson Cancer Center, TX | 90,546 citations |
| 4 | Marina KonoplevaAlbert Einstein College of Medicine | 71,749 citations |
| 5 | Farhad Ravandi-KashaniThe University of Texas MD Anderson Cancer Center, TX | 71,079 citations |
| 6 | Stephan GruppChildren's Hospital of Philadelphia, PA | 64,125 citations |
| 7 | Francis GilesTX | 60,986 citations |
| 8 | Malcolm BrennerBaylor College of Medicine, TX | 59,020 citations |
| 9 | Mary HorowitzMedical College of Wisconsin, WI | 57,794 citations |
| 10 | Elias JabbourThe University of Texas MD Anderson Cancer Center, TX | 56,927 citations |
| 11 | David MaloneyFred Hutchinson Cancer Center, WA | 54,034 citations |
| 12 | Hillard LazarusCase Western Reserve University School of Medicine, OH | 50,317 citations |
| 13 | Elizabeth ShpallThe University of Texas MD Anderson Cancer Center, TX | 48,319 citations |
| 14 | Corey CutlerDana-Farber Cancer Institute, MA | 42,105 citations |
| 15 | Daniel DeangeloDana-Farber Cancer Institute, MA | 38,550 citations |
| 16 | Philippe ArmandMayo Clinic, MN | 38,160 citations |
| 17 | Stefan FaderlJazz Pharmaceuticals, NJ | 38,127 citations |
| 18 | Brenda SandmaierFred Hutchinson Cancer Center, WA | 36,879 citations |
| 19 | Joanne KurtzbergDuke University Medical Center, NC | 35,382 citations |
| 20 | Patricia LorussoYale School of Medicine, MI | 34,992 citations |
| 21 | Tapan KadiaThe University of Texas MD Anderson Cancer Center, TX | 33,581 citations |
| 22 | Wendy StockUniversity of Chicago, IL | 29,648 citations |
| 23 | Mitchell CairoNew York Medical College, NY | 27,810 citations |
| 24 | Partow KebriaeiThe University of Texas MD Anderson Cancer Center, TX | 27,445 citations |
| 25 | James KochenderferNational Cancer Institute Surgery Branch, MD | 27,340 citations |
Most NIH awards
NIH awards on the person's record in NIH RePORTER, across all of their funded work, among the people with at least two registered trials in this indication. 55 of the 277 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: NIH RePORTER.
| # | Expert | awards |
|---|---|---|
| 1 | Marina KonoplevaAlbert Einstein College of Medicine | 12 awards |
| 2 | Malcolm BrennerBaylor College of Medicine, TX | 12 awards |
| 3 | Brenda SandmaierFred Hutchinson Cancer Center, WA | 11 awards |
| 4 | Stephan GruppChildren's Hospital of Philadelphia, PA | 9 awards |
| 5 | Mitchell CairoNew York Medical College, NY | 9 awards |
| 6 | Richard AplencChildren's Hospital of Philadelphia, PA | 8 awards |
| 7 | Mary HorowitzMedical College of Wisconsin, WI | 8 awards |
| 8 | Elizabeth ShpallThe University of Texas MD Anderson Cancer Center, TX | 7 awards |
| 9 | Joanne KurtzbergDuke University Medical Center, NC | 7 awards |
| 10 | Michael PulsipherCA | 6 awards |
| 11 | Saro ArmenianCity of Hope, CA | 6 awards |
| 12 | Marie BleakleySeattle Children's Hospital, WA | 5 awards |
| 13 | Colleen DelaneyWA | 5 awards |
| 14 | Smita BhatiaAL | 5 awards |
| 15 | Hillard LazarusCase Western Reserve University School of Medicine, OH | 5 awards |
| 16 | Ajay GopalUniversity of Washington School of Medicine, WA | 5 awards |
| 17 | Hagop KantarjianThe University of Texas MD Anderson Cancer Center, TX | 4 awards |
| 18 | Emmanuel KatsanisUniversity of Arizona, AZ | 4 awards |
| 19 | Terzah HortonBaylor College of Medicine, TX | 4 awards |
| 20 | Akil MerchantCedars-Sinai Medical Center, CA | 4 awards |
| 21 | Patricia LorussoYale School of Medicine, MI | 4 awards |
| 22 | Geoffrey UyWashington University School of Medicine, MO | 4 awards |
| 23 | Guillermo Garcia-ManeroThe University of Texas MD Anderson Cancer Center, TX | 3 awards |
| 24 | Judith KarpJohns Hopkins University School of Medicine, MD | 3 awards |
| 25 | Sawa ItoUniversity of Pittsburgh, PA | 3 awards |
Most congress contributions
Congress abstracts and presentations attributed to the person and verified by DOI, across every meeting the directory tracks, among the people with at least two registered trials in this indication. 40 of the 277 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: Congress abstracts, DOI-verified.
| # | Expert | contributions |
|---|---|---|
| 1 | Hagop KantarjianThe University of Texas MD Anderson Cancer Center, TX | 859 contributions |
| 2 | Farhad Ravandi-KashaniThe University of Texas MD Anderson Cancer Center, TX | 677 contributions |
| 3 | Jorge CortesUniversity of Alabama at Birmingham (UAB), AL | 654 contributions |
| 4 | Patricia LorussoYale School of Medicine, MI | 272 contributions |
| 5 | Daniel DeangeloDana-Farber Cancer Institute, MA | 229 contributions |
| 6 | Eunice WangRoswell Park Comprehensive Cancer Center, NY | 222 contributions |
| 7 | Elizabeth ShpallThe University of Texas MD Anderson Cancer Center, TX | 217 contributions |
| 8 | Wendy StockUniversity of Chicago, IL | 210 contributions |
| 9 | Partow KebriaeiThe University of Texas MD Anderson Cancer Center, TX | 202 contributions |
| 10 | Anthony SteinCity of Hope, CA | 171 contributions |
| 11 | Ibrahim AldossCity of Hope, CA | 151 contributions |
| 12 | Geoffrey UyWashington University School of Medicine, MO | 130 contributions |
| 13 | David MaloneyFred Hutchinson Cancer Center, WA | 127 contributions |
| 14 | Ryotaro NakamuraCity of Hope, CA | 125 contributions |
| 15 | Philippe ArmandMayo Clinic, MN | 111 contributions |
| 16 | Ajay GopalUniversity of Washington School of Medicine, WA | 111 contributions |
| 17 | Stephan GruppChildren's Hospital of Philadelphia, PA | 108 contributions |
| 18 | Amandeep SalhotraCity of Hope, CA | 104 contributions |
| 19 | Ryan CassadayUniversity of Washington, WA | 103 contributions |
| 20 | Mitchell CairoNew York Medical College, NY | 100 contributions |
| 21 | Brian JonasUniversity of California, Davis, CA | 96 contributions |
| 22 | Saro ArmenianCity of Hope, CA | 87 contributions |
| 23 | Sumithira VasuThe Ohio State University, OH | 79 contributions |
| 24 | Corey CutlerDana-Farber Cancer Institute, MA | 69 contributions |
| 25 | Noelle FreyUniversity of Pennsylvania, PA | 60 contributions |
Emerging
6 of the 277 carry the Emerging flag: publication and trial activity rising over the recent three years, in the top ten percent for growth among specialty peers at a similar career stage. Listed A to Z, not ranked; the flag is a yes or nothing, never a score. How the flag is computed.
| Melissa AlsinaMoffitt Cancer Center, FL |
| Alexandra DreyzinDC |
| Tanja GruberStanford University School of Medicine, CA |
| Douglas HawkinsSeattle Children's Hospital, WA |
| Yael MosseChildren's Hospital of Philadelphia, PA |
| Joshua ZeidnerUniversity of North Carolina at Chapel Hill, NC |
How these tables are computed
The cohort is every profile in the directory tagged to Precursor Cell Lymphoblastic Leukemia-Lymphoma, from the person's registered trials and published research. Only indications with at least 200 tagged people get a page; a smaller cohort would say more about the tag than about the people in it. Each table sorts the cohort by one count, highest first, with no weighting, no blending and no editorial pass. Ties are broken by the profile's stable internal id so the same counts always give the same order. A person with no count on record is left out of that table, not ranked last.
Citations, NIH awards and congress contributions are counts over a person's whole record, not their work in this indication alone, so those three tables are limited to the indication's investigators: people with at least 2 registered trials in it. Without that rule the most cited people in a cohort are the ones whose careers span many diseases, which is a fact about their careers, not about this field. The registered-trials table is the indication-scoped count itself and has no such limit.
The counts are recomputed on every publish and the page carries the date of the publish it was built from. Previous editions are superseded, not archived.
What is deliberately absent
Reported industry payments are on every profile but are not a table here: a count of payers is a fact, and ranking people by it reads as a judgment. Prescribing volume is part of the paid workspace. The directory's influence tier is a judgment and never orders a public page. Sources and methodology.
Filter, sort and open every Precursor Cell Lymphoblastic Leukemia-Lymphoma profile in the directory